[1]陈绵雄,林慧,张菊云,等.青年2型糖尿病患者血清25羟维生素D3水平与代谢综合征的关系[J].国际内分泌代谢杂志,2021,41(06):601-605.[doi:10.3760/cma.j.cn121383-20200606-06016]
　Chen Mianxiong,Lin Hui,Zhang Juyun,et al.Relationship between serum 25-hydroxyvitamin D3 level and the risk of metabolic syndrome in young patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2021,41(06):601-605.[doi:10.3760/cma.j.cn121383-20200606-06016]
点击复制

青年2型糖尿病患者血清25羟维生素D3水平与代谢综合征的关系()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
41
期数:
2021年06期
页码:
601-605
栏目:
论著
出版日期:
2021-12-20

文章信息/Info

Title:
Relationship between serum 25-hydroxyvitamin D3 level and the risk of metabolic syndrome in young patients with type 2 diabetes mellitus
作者:
陈绵雄; 林慧; 张菊云; 刘婷婷
中南大学湘雅附属海口医院/海口市人民医院内分泌科 570208
Author(s):
Chen Mianxiong;  Lin Hui;  Zhang Juyun;  Liu Tingting.
Department of Endocrinology, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine/Haikou people's Hospital, Haikou 570208, China
关键词:
2型糖尿病;  25羟维生素D3;  代谢综合征;  青年
Keywords:
Type 2 diabetes mellitus;  Serum 25-hydroxyvitamin D3;  Metabolic syndrome;  Youth
DOI:
10.3760/cma.j.cn121383-20200606-06016
摘要:
目的 探讨青年2型糖尿病患者血清25羟维生素D3[25(OH)D3]水平与代谢综合征(MS)患病风险的关系。方法 选取16～44岁的448例2型糖尿病患者,根据是否合并MS分为对照(CON)组(159例)和MS组(289例),比较两组患者生化代谢指标水平以及血清25(OH)D3缺乏情况,分析血清25(OH)D3水平与MS的相关性。结果 MS组血清25(OH)D3水平明显低于CON组(P<0.05)。与CON组比较,MS组吸烟史明显更长(P<0.05),腰围、腰臀比、体重指数、空腹血糖、收缩压、舒张压、甘油三酯明显增高,高密度脂蛋白-胆固醇(HDL-C)和25(OH)D3水平明显降低(P均<0.05)。不同代谢性疾病中血清25(OH)D3缺乏情况比较,各组腹型肥胖、高血压、高甘油三酯、低HDL-C患者数,均有显著差异,血清25(OH)D3缺乏>不足>充足(P均<0.05),血清25(OH)D3水平与吸烟、腰围、腰臀比、体重指数、空腹血糖、糖化血红蛋白A1c(HbA1c)、收缩压、舒张压、甘油三酯、LDL-C呈负相关,与HDL-C呈正相关,多元logistic回归分析显示血清25(OH)D3充足是T2DM合并MS的独立保护因素。结论 青年T2DM患者血清25(OH)D3水平与MS患病风险呈独立负相关。
Abstract:
Objective Investigate the relationship between serum 25-hydroxyvitamin D3[25(OH)D3] level and the risk of metabolic syndrome(MS)in young patients with type 2 diabetes.Methods A total of 448 type 2 diabetes mellitus patients aged 16 to 44 years were selected as the study subjects. The patients were divided into the control(CON)group(159 cases)and the MS group(289 cases)based on whether the patients had MetS. The levels of biochemical and metabolic indicators and the lack of serum 25(OH)D3 were compared between the two groups, and the correlation between serum 25(OH)D3 levels and MS was analyzed.Results The serum 25(OH)D3 level in MS group was significantly lower than that in CON group(P<0.05). Compared with CON group, the smoking history of the MS group was significantly longer(P<0.05), waist circumference, waist-hip ratio, body mass index(BMI), fasting blood glucose, systolic blood pressure, diastolic blood pressure, triglyceride were significantly increased, and high density lipoprotein cholesterol(HDL-C)and 25(OH)D3 levels were significantly reduced(all P<0.05). The number of MS components decreased in the order of serum 25(OH)D3 deficiency>insufficient>sufficient(all P<0.05). The serum 25(OH)D3 level was related to smoking, waist circumference, waist-hip ratio, and BMI, FBG, hemoglobinA1c(HbA1c), systolic blood pressure, diastolic blood pressure, triglyceride, and low density lipoprotein cholesterol(LDL-C)were negatively correlated and positively correlated with HDL-C. Multiple logistic regression analysis showd that sufficient serum 25(OH)D3 was an independent protective factor for T2DM with MS.Conclusion In young patients with type 2 diabetes, serum 25(OH)D3 levels are independently and negatively related to the risk of MS.

参考文献/References:

[1] Wang L,Gao P,Zhang M,et al.Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013 [J].JAMA,2017,317(24):2515-2523.DOI:10.1001/jama.2017.7596.
[2] Li Y,Teng D,Shi X,et al.Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association:national cross sectional study [J].BMJ,2020,369:m997.DOI:10.1136/bmj.m997.
[3] Maron BA,Leopold JA,Hemnes AR.Metabolic syndrome,neurohumoral modulation,and pulmonary arterial hypertension [J].Br J Pharmacol,2020,177(7):1457-1471.DOI:10.1111/bph.14968.
[4] He Y,Li Y,Bai G,et al.Prevalence of metabolic syndrome and individual metabolic abnormalities in China,2002-2012 [J].Asia Pac J Clin Nutr,2019,28(3):621-633.DOI:10.6133/apjcn.201909_28(3).0023.
[5] Käräjämäki AJ,Hukkanen J,Kauma H,et al.Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD(OPERA study)[J].Scand J Clin Lab Invest,2020,80(2):106-113.DOI:10.1080/00365513.2019.1700428.
[6] Elsamna S,Elkattawy O,Merchant AM.Association of metabolic syndrome with morbidity and mortality in emergency general surgery [J].Am J Surg,2020,220(2):448-453.DOI:10.1016/j.amjsurg.2019.12.021.
[7] Bruno G,Merletti F,Biggeri A,et al.Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes:the Casale Monferrato Study [J].Diabetes Care,2004,27(11):2689-2694.DOI:10.2337/diacare.27.11.2689.
[8] Barbalho SM,Tofano RJ,de Campos AL,et al.Association between vitamin D status and metabolic syndrome risk factors [J].Diabetes Metab Syndr,2018,12(4):501-507.DOI:10.1016/j.dsx.2018.03.011.
[9] Alkhatatbeh MJ,Abdul-Razzak KK,Khasawneh LQ,et al.High prevalence of vitamin D deficiency and correlation of serum vitamin D with cardiovascular risk in patients with metabolic syndrome [J].Metab Syndr Relat Disord,2017,15(5):213-219.DOI:10.1089/met.2017.0003.
[10] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.DOI:10.19538/j.nk2018040108.
[11] 夏维波,李梅.维生素D缺乏的评价、预防及治疗——内分泌学会临床实践指南[J].中华骨质疏松和骨矿盐疾病杂志,2011,4(2):144-146.DOI:10.3969/j.issn.1674-2591.2011.02.014.
[12] 柳传威,洪秀韬,杨燕,等.2型糖尿病患者血清维生素D水平与代谢综合征的相关性研究 [J].中华内分泌代谢杂志,2019,35(7):564-569.DOI:10.3760/cma.j.issn.1000-6699.2019.07.005.
[13] 黄花,徐冬冬,任建宇.2型糖尿病合并高尿酸血症青年患者代谢相关因素分析 [J]. 中国现代医学杂志,2020,30(21):53-57.DOI:10.3969/j.issn.1005-8982.2020.21.011.
[14] Bouchemal M,Hakem D,Azzouz M,et al.Vitamin D levels correlate with metabolic syndrome criteria in algerian patients:the ex-vivo immunomodulatory effect of α,25 dihydroxyvitamin D3 [J].Endocr Metab Immune Disord Drug Targets,2020,20(8):1282-1294.DOI:10.2174/1871530320666200402121917.
[15] 修双玲,穆志静,孙丽娜,等.老年2型糖尿病代谢综合征患者骨质疏松危险因素研究 [J].首都医科大学学报,2020,41(1):108-112.DOI:10.3969/j.issn.1006-7795.2020.01.021.
[16] 李嘉伟,卫刚刚,庞有成,等.2型糖尿病患者血清25-羟维生素D和甲状旁腺激素水平与高血压病的相关性 [J].中国动脉硬化杂志,2019,27(12):1071-1074.
[17] 文海清,郭娟,雷晓珍,等.青年2型糖尿病患者血清25-羟维生素D3水平与糖尿病周围神经病变的关系 [J].广西医学,2019,41(21):2701-2704.DOI:10.11675/j.issn.0253-4304.2019.21.06.
[18] Al-Daghri NM,Amer OE,Khattak MNK,et al.Effects of different vitamin D supplementation strategies in reversing metabolic syndrome and its component risk factors in adolescents [J].J Steroid Biochem Mol Biol,2019,191:105378.DOI:10.1016/j.jsbmb.2019.105378.
[19] 张晓蕾,敖娜,都健.维生素D以肠道菌群为靶点治疗非酒精性脂肪性肝病的研究进展[J].国际内分泌代谢杂志,2019,39(5):311-314.DOI:10.3760/cma.j.issn.1673-4157.2019.05.006.

相似文献/References:

[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍：2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
　Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(06):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[4]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
　Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(06):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[5]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
　Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(06):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[6]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
　Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(06):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[7]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
　Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(06):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[8]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
　Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(06):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[9]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
　Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(06):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[10]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
　Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(06):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
[11]刘东玲 赵崇强 李春君 陈丽琴 邱慧娜 林静娜.2型糖尿病合并肿瘤患者血清维生素D水平 及其危险因素分析[J].国际内分泌代谢杂志,2020,40(04):217.[doi:10.3760/cma.j.issn.1673-4157.2020.04.001]
　Liu Dongling,Zhao Chongqiang,Li Chunjun,et al.Analysis of the level of serum vitamin D and the risk factors of patients with type 2 diabetes mellitus complicated with tumor[J].International Journal of Endocrinology and Metabolism,2020,40(06):217.[doi:10.3760/cma.j.issn.1673-4157.2020.04.001]

备注/Memo

备注/Memo:
通信作者:刘婷婷,Email: 15120014@qq.com
更新日期/Last Update: 2021-12-10